Table 1. Clinically Relevant Mutations in the S Gene and Corresponding Results in Patients 1 and 2.*.
Mutation | Patient 1 | Patient 2 |
---|---|---|
69/70 deletion | Not detected | Not detected |
D80A | Not detected | Not detected |
T95I | Detected | Detected |
D138Y | Not detected | Not detected |
del142–145 | Detected (del144) | Detected (G142V, del144) |
R190T | Not detected | Detected |
D215G | Not detected | Not detected |
F220I | Not detected | Detected |
R237K | Not detected | Detected |
Δ242–244 | Not detected | Not detected |
R246T | Not detected | Detected |
D253G | Not detected | Not detected |
K417T | Not detected | Undetermined |
L452R | Not detected | Undetermined |
S477N | Not detected | P/H† |
E484K | Detected | Undetermined |
N501Y | Not detected | Undetermined |
A570D | Detected | Not detected |
D614G | Detected | Detected |
H655Y | Not detected | Not detected |
P681H | Detected | P/H† |
A701V | Not detected | Undetermined |
D796H | Detected | Undetermined |
These mutations are defined by the Centers for Disease Control and Prevention.6
P/H indicates partial heterozygosity (sequences from both the variant strain and the original strain first identified in Wuhan, China, were detected).